Biblio
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. Hematol Oncol. 2023.
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. Blood Adv. 2022;6(13):3875-3878.